salsolinol has been researched along with levodopa in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allievi, C; Bellotti, V; Benedetti, MS; Dordain, G; Dostert, P | 1 |
Dordain, G; Dostert, P; Strolin Benedetti, M; Vernay, D | 1 |
Clow, A; Murray, R; Sandler, M; Saunders, JB; Topham, A | 1 |
Sjöquist, B | 1 |
Dostert, P; Maruyama, W; Naoi, M; Narabayashi, H | 1 |
Antkiewicz-Michaluk, L; Krygowska-Wajs, A; Romańska, I; Szczudlik, A; Vetulani, J | 1 |
Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P | 1 |
Fekete, MI; Fülöp, F; Homicskó, KG; Kertész, I; Nagy, GM; Radnai, B; Tóth, BE; Tóth, G | 1 |
Klingemann, I; Moser, A; Scholz, J | 1 |
Fülöp, F; Hara, S; Hashizume, T; Jin, J; Nagy, GM; Sawai, K | 1 |
Antkiewicz-Michaluk, L; Michaluk, J; Romańska, I; Wąsik, A | 1 |
Fülöp, F; Hashizume, T; Inaba, Y; Nagy, GM; Sawai, K; Watanabe, R | 1 |
2 trial(s) available for salsolinol and levodopa
Article | Year |
---|---|
Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.
Topics: Aged; Antiparkinson Agents; Body Fluids; Cerebral Ventricles; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Molecular Structure; Neurotoxins; Parkinson Disease; Stereoisomerism | 1996 |
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.
Topics: Adult; Aged; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dementia; Female; Homovanillic Acid; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Tyrosine | 1997 |
10 other study(ies) available for salsolinol and levodopa
Article | Year |
---|---|
Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects.
Topics: Adult; Benserazide; Dopamine; Drug Combinations; Female; Humans; Hydrazines; Isoquinolines; Levodopa; Male; Stereoisomerism | 1990 |
Enantiomeric composition of urinary salsolinol in parkinsonian patients after Madopar.
Topics: Aged; Aged, 80 and over; Benserazide; Drug Combinations; Female; Humans; Hydrazines; Isoquinolines; Levodopa; Male; Middle Aged; Parkinson Disease; Stereoisomerism | 1989 |
The role of salsolinol in alcohol intake and withdrawal.
Topics: Acetaldehyde; Alcoholism; Ethanol; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Time Factors | 1985 |
On the origin of salsolinol and 1-carboxysalsolinol.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Energy Metabolism; Ethanol; Humans; Isoquinolines; Levodopa; Male; Rats; Rats, Inbred Strains; Salsoline Alkaloids | 1985 |
Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Biomarkers; Catecholamines; Female; Hallucinations; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Isoquinolines; Levodopa; Male; Parkinson Disease; Reference Values; Regression Analysis; Tyrosine | 1996 |
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Binding Sites; Binding, Competitive; Brain; Carbidopa; Clonidine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Isoquinolines; Kinetics; Lactation; Levodopa; Male; Mazindol; Median Eminence; Methyldopa; Pituitary Gland; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine | 2003 |
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Biomarkers; Chromatography, High Pressure Liquid; Female; Humans; Inactivation, Metabolic; Isoquinolines; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Reference Values; Salsoline Alkaloids | 2004 |
Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats.
Topics: Animals; Carbidopa; Dopamine; Goats; Hypothalamus; Injections, Intravenous; Isoquinolines; Levodopa; Male; Photoperiod; Prolactin; Stimulation, Chemical; Time Factors | 2014 |
Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.
Topics: Animals; Brain; Dopamine; Dopamine Agents; Hyperkinesis; Isoquinolines; Levodopa; Male; Motor Activity; Rats; Rats, Wistar | 2015 |
Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
Topics: Animals; Carbidopa; Dopamine; Dopamine D2 Receptor Antagonists; Drug Combinations; Female; Goats; Haloperidol; Hypothalamus; Injections, Intravenous; Isoquinolines; Levodopa; Prolactin; Thyrotropin-Releasing Hormone | 2017 |